Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hematopoietic stem cell transplantation]

Y Kohgo1, S Sakamaki, Y Hirayama

  • 1Third Department of Internal Medicine, Asahikawa Medical College, Japan.

[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation of lymphokine activated killer cells in a new high density dialyzing culture apparatus.

Cytotechnology·2012
Same author

Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.

Leukemia·2005
Same author

Autoimmune hemolytic anemia as a first manifestation of primary effusion lymphoma.

Annals of hematology·2003
Same author

A case of true malignant histiocytosis: identification of histiocytic origin with use of immunohistochemical and immunocytogenetic methods.

Annals of hematology·2002
Same author

Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide.

Internal medicine (Tokyo, Japan)·2002
Same author

[Ulcerative colitis associated with relapsing polychondritis].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2002
Same journal

[The clinical condition and treatment of diseases associated with sudden death].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
Same journal

[The new era of anemia in the elderly].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
Same journal

[Lifestyle and health: results from epidemiological studies].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
Same journal

[Clinical significance of awake neurosurgery].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
Same journal

[Current understanding of the mechanism of undesirable transfusion reaction and the preventive strategires against them].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
Same journal

[AMED: Missions and Challenges].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
See all related articles

Hematopoietic stem cell transplantation, using cells from bone marrow or peripheral blood, aids recovery from chemotherapy side effects. This approach shows promise for treating chemotherapy-curable cancers like choriocarcinoma.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Context:

  • Chemotherapy advancements offer cures for various malignancies but require higher doses, risking bone marrow failure.
  • Hematopoietic stem cells (HSCs) from bone marrow or peripheral blood can mitigate chemotherapy-induced neutropenia and thrombocytopenia.

Purpose:

  • To evaluate the long-term engraftment and differentiation potential of HSCs from bone marrow and peripheral blood in SCID mice.
  • To assess the efficacy of high-dose chemotherapy combined with peripheral blood stem cell transplantation (PBSCT) for poor-risk choriocarcinoma patients.

Summary:

  • Stem cells isolated using anti-CD34 magnetic beads demonstrated sustained hematopoietic cell production and human IgG in SCID mice post-transplantation.
  • Clinical trials combining high-dose chemotherapy with PBSCT for choriocarcinoma yielded improved response rates (4 CR, 4 PR) compared to conventional therapies (5 PR, 2 PD, 1 NC).

Related Experiment Videos

Impact:

  • Peripheral blood stem cells exhibit comparable long-term maturation potential to bone marrow stem cells.
  • This combined treatment regimen presents a promising therapeutic strategy for improving outcomes in chemotherapy-curable tumors.